IP Library › Granted Patent US 12,423,547
Granted Patent B2
US 12,423,547 · App. 18/781,206 · Granted Sep 23, 2025

Radio frequency identification (RFID) inlays for use with medical injection devices

Inventors: Alfred Leibbrand (Claix, FR); Nicolas Euvrard (London, GB); Cédric Rivier (Voreppe, FR); Gwenn Le Dimet (Charavines, FR); Damien Maréchal (Claix, FR); Thierry Vasquez (Vaulnaveys-le-Haut, FR)
Assignees: Becton, Dickinson and Company; Becton Dickinson France
G06K19/0723A61M39/20G09F3/0295
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,423,547
App. No.
18/781,206
Granted
Sep 23, 2025
Kind
B2
Abstract

A tip cap assembly for coupling with a syringe body includes a luer lock adaptor, a rigid cap coupled to the luer lock adaptor; a rigid tip cap having distal end and proximal ends, the rigid tip cap being disposed at least partially within the rigid cap, a RFID tag positioned over the distal end of the tip cap, and an adhesive layer formed over the RFID tag. Also provided is RFID inlay for use with medical devices including a meshed substrate, and a RFID antenna and integrated circuit assembly adhered to the meshed substrate. A syringe and label assembly is disclosed, including a body having distal and proximal ends, a tip cap assembly having distal end and proximal ends, and a label at least partially surrounding the distal end of the syringe body and the proximal end of the tip cap, the label comprises an integrated RFID tag.

Claims (21)

1. A syringe and label assembly comprising:

a syringe body having a distal end and a proximal end;

a tip cap assembly having a distal end and a proximal end; and

a label at least partially surrounding the distal end of the syringe body and the proximal end of the tip cap assembly,

wherein the label comprises an integrated RFID tag.

2. The syringe and label assembly of claim 1 , wherein the label is formed of a tubular, heat-shrinkable material.

3. The syringe and label assembly of claim 1 , wherein the tip cap assembly is a needle shield assembly comprising an inner flexible shield and an outer rigid shield.

4. The syringe and label assembly of claim 1 , wherein the outer rigid shield is a plastic rigid shield, and the inner flexible shield is made of a rubber material.

5. The syringe and label assembly of claim 1 , wherein the label further comprises a tear-off etching line.

6. The syringe and label assembly of claim 5 , wherein the tear-off etching line passes through a portion of the integrated RFID tag.

7. The syringe and label assembly of claim 1 , wherein the label comprises an RFID inlay, the RFID inlay comprising:

a meshed substrate; and

a RFID antenna and integrated circuit chip assembly adhered to the meshed substrate.

8. The syringe and label assembly of claim 7 , wherein the meshed substrate is porous and gas permeable.

9. The syringe and label assembly of claim 7 , wherein the meshed substrate is formed of high-density spunbound polyethylene fibers.

10. A label for use with syringe and tip cap assemblies, the label comprising:

a tubular body;

a RFID tag adhered to, or formed as part of, the tubular body; and

a tear-off etching line configured to break the tubular body.

11. The label of claim 10 , wherein the tubular body is formed of a heat-shrinkable material.

12. The label of claim 10 , wherein the tear-off etching line passes through a portion of the RFID tag.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2024
From: LEIBBRAND, ALFRED; EUVRARD, NICOLAS; RIVIER, CÉDRIC; LE DIMET, GWENN; MARÉCHAL, DAMIEN; VASQUEZ, THIERRY
To: BECTON, DICKINSON AND COMPANY; BECTON DICKINSON FRANCE
Reel/Frame 068247/0656 →
Continuity (4)
Continuation 17922101
Provisional Application 63124126 · Dec 11, 2020
Provisional Application 63108497 · Nov 2, 2020
Related Publication 20240378408A1 · Nov 14, 2024
References Cited (27)
US 8695819B1 · Anderson · 2014 [cited by applicant]
US 9311592B1 · Vitello et al. · 2016 [cited by applicant]
US 10035624B2 · Bauss · 2018 [cited by applicant]
US 10661935B2 · McKinnon et al. · 2020 [cited by applicant]
US 20020188259A1 · Hickle et al. · 2002 [cited by applicant]
US 20050023173A1 · Paoletti · 2005 [cited by examiner]
US 20080306443A1 · Neer et al. · 2008 [cited by applicant]
US 20150090625A1 · Bauss · 2015 [cited by applicant]
US 20200164161A1 · Murray et al. · 2020 [cited by applicant]
US 20200268480A1 · Bauss et al. · 2020 [cited by applicant]
US 20210236736A1 · Murray et al. · 2021 [cited by applicant]
US 20220180143A1 · Rehm · 2022 [cited by applicant]
US 20220257872A1 · Geissler · 2022 [cited by examiner]
US 20230023532A1 · Oetzel et al. · 2023 [cited by applicant]
DE 102019108253A1 · 2020 [cited by applicant]
EP 4152300A1 · 2023 [cited by applicant]
JP 200242096A · 2002 [cited by applicant]
JP 200871071A · 2008 [cited by applicant]
JP 2008150903A · 2008 [cited by applicant]
JP 201969393A · 2019 [cited by applicant]
WO 2009104362A1 · 2009 [cited by applicant]
WO 2019189449A1 · 2019 [cited by applicant]
WO 2019189451A1 · 2019 [cited by applicant]
WO 2020194644A1 · 2020 [cited by applicant]
WO 2020219482A1 · 2020 [cited by applicant]
WO 2021001291A1 · 2021 [cited by applicant]
WO WO2022094382A1 · 2022 [cited by examiner]